Latest Asx Company Filings News

Tamboran Resources has reported a record IP30 flow rate of 7.2 MMcf/d from its Shenandoah South 2H ST1 well, matching top US shale benchmarks and paving the way for a 40 MMcf/d pilot project by mid-2026.

Tamboran Resources has reported a record 30-day initial production flow rate from its Shenandoah South 2H sidetrack well in the Beetaloo Basin, aligning with prolific US shale benchmarks and setting the stage for commercial gas sales by mid-2026.

Vulcan Steel announces a significant leadership transition with CEO Rhys Jones retiring after nearly two decades, handing the reins to Gavin Street from January 2026. The board reshuffle also sees Jones moving to non-executive Chair, ensuring continuity at the top.

Western Gold Resources has secured a binding toll milling agreement with Wiluna Mining Corporation to process ore from its Gold Duke Project, marking a pivotal step towards production.

Horizon Oil has commenced production from its newly drilled A9H infill well in China’s Beibu Gulf, revealing an unanticipated oil reservoir that could boost future output.

The Calmer Co. has secured a major retail milestone by launching its Fiji Kava 50g Instant Kava product across Woolworths supermarkets nationwide, significantly broadening its Australian footprint.

Unith Limited reports a remarkable 1100% increase in users on its Digital Humans platform over the past year, driven by organic growth and strategic global partnerships. The company is poised to accelerate growth with upcoming marketing campaigns and high-profile industry events.

4DS Memory reports initial testing of its latest 20nm memory cell arrays fell short of expectations, potentially delaying its Interface Switching ReRAM technology development. Further analysis and testing are underway to pinpoint the issues.

Harvest Technology Group’s CEO, Ilario Faenza, has stepped in with a $500,000 unsecured loan to support the company’s working capital, highlighting ongoing liquidity management efforts.

Polymetals Resources has officially commenced commercial production at its Endeavor silver zinc mine in Cobar, NSW, with zinc concentrate shipments set to begin in early July 2025. The company is progressing steadily toward ramping up output in the second half of the year.

Nyrada’s Phase I clinical trial for its novel drug Xolatryp has cleared safety reviews through four cohorts and will now test higher doses and longer infusions in an expanded trial design.

EVE Health Group’s subsidiary Nextract has inked a pivotal two-year agreement with TeleDocs Clinic, enabling nationwide online prescribing of its upcoming erectile dysfunction and dysmenorrhea products ahead of regulatory approval.